Researchers from University of Arizona Health Sciences are one step closer to solving one of the biggest barriers to regenerative medicine: immunological rejection by the recipient.
T cells are the key immune system component involved in killing cancer. Tumors produce signals that turn off these T cells, partially by forcing them to progressively differentiate (mature) into a hypofunctional state known as exhaustion.
/PRNewswire/ Scientists at St. Jude Children s Research Hospital identified a molecular mechanism that in a preclinical study unlocked the promise of CAR.
/PRNewswire/ Scientists from St. Jude Children s Research Hospital have shown that the innate immune sensor, ZBP1, and its associated inflammatory cell.